 |
Probiotics? How do you choose?
|
The SpineCommunity Presents: Ask the Expert with Dr. David Borenstein David G. Borenstein, MD recently answered your questions on ankylosing spondylitis (AS) in TheSpineCommunity. ...
Doctors have reported the results of a novel targeted therapy that may represent a new treatment option for individuals with Crohn’s disease. Risankizumab is a ...
Crohn’s disease is an idiopathic, chronic, inflammatory process that can affect any part of the gastrointestinal (GI) tract from the mouth to the anus. Individuals ...
Almost 700,000 people in the U.S. suffer from Crohn’s disease however each individuals experience with the chronic illness is unique and can differ significantly from others. For ...
Managing a chronic disease, such as Crohn’s disease or ulcerative colitis is difficult enough to begin with and can be made much more difficult if ...
 |
 |
 |
